Akèy › Timò Nèwo-endokrin › Pennsylvania › Philadelphia
Etid klinik pou Timò Nèwo-endokrin nan Philadelphia, PA
11 etid pou Timò Nèwo-endokrin ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Ap rekriteFaz 2/3
- University of Pennsylvania, Philadelphia
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Ap rekriteFaz 1
- The Children's Hospital of Philadelphia (CHOP), Philadelphia
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Ap rekriteFaz 3
- Hospital of the University of Pennsylvania, Philadelphia
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- Drexel University School of Medicine, Philadelphia
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- ak 1 plis
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Ap rekriteFaz 1/2
- Crinetics Study Site, Philadelphia
- Crinetics Study Site, Philadelphia
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Ap rekriteFaz 2
- Fox Chase Cancer Center, Philadelphia
CapTemY90 for Grade 2/3 NET Liver Metastases
Ap rekriteFaz 2
- University of Pennsylvania, Philadelphia
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Ap rekriteFaz 1/2
- University of Pennsylvania, Philadelphia
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Ap rekriteFaz 1/2
- University of Pennsylvania, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Ap rekriteFaz 4
- Albert Einstein Healthcare Network, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Philadelphia
Etid Timò Nèwo-endokrin nan lòt vil
- Washington, DC11 etid
- Rochester, MN9 etid
- Houston, TX8 etid
- Columbus, OH7 etid
- St. Louis, MO7 etid
- Chicago, IL7 etid
- Detroit, MI7 etid
- Salt Lake City, UT7 etid
- Cleveland, OH7 etid
- Dallas, TX6 etid
- Lexington, KY6 etid
- New York City, NY6 etid
Lòt etid nan Philadelphia
- Kansè (tout kalite)59 etid
- Kansè nan tete56 etid
- Kansè Poumon ki pa ti selil51 etid
- Kansè Metastatik46 etid
- Kansè pwostat44 etid
- Kansè kolorektal44 etid
- Kansè ovè44 etid
- Kansè poumon36 etid
- Leksemi mieloïd egi34 etid
- Ensifizyans kadyak31 etid
- Kansè Endomèt28 etid
- Depresyon26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.